BRUNO, ANTONINO
 Distribuzione geografica
Continente #
NA - Nord America 9.487
EU - Europa 5.561
AS - Asia 3.982
SA - Sud America 496
AF - Africa 87
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 15
Totale 19.648
Nazione #
US - Stati Uniti d'America 9.286
IT - Italia 2.956
SG - Singapore 1.388
CN - Cina 866
VN - Vietnam 487
HK - Hong Kong 474
UA - Ucraina 435
BR - Brasile 402
DE - Germania 401
SE - Svezia 351
GB - Regno Unito 255
TR - Turchia 252
FR - Francia 249
IE - Irlanda 220
FI - Finlandia 196
RU - Federazione Russa 153
BD - Bangladesh 141
CA - Canada 109
IN - India 101
JP - Giappone 78
MX - Messico 69
NL - Olanda 65
ES - Italia 50
PL - Polonia 48
AR - Argentina 37
ZA - Sudafrica 34
AT - Austria 32
CZ - Repubblica Ceca 29
BE - Belgio 28
IQ - Iraq 25
ID - Indonesia 21
CH - Svizzera 19
MY - Malesia 19
LT - Lituania 18
NG - Nigeria 16
AU - Australia 15
PK - Pakistan 15
EC - Ecuador 13
TH - Thailandia 12
EU - Europa 11
SA - Arabia Saudita 11
CL - Cile 10
CO - Colombia 10
IR - Iran 10
KR - Corea 10
VE - Venezuela 10
PH - Filippine 9
AE - Emirati Arabi Uniti 8
TN - Tunisia 8
UZ - Uzbekistan 8
IL - Israele 7
MA - Marocco 7
PY - Paraguay 7
RO - Romania 7
TW - Taiwan 7
GR - Grecia 6
KE - Kenya 6
MD - Moldavia 6
DK - Danimarca 5
DZ - Algeria 5
EG - Egitto 5
NP - Nepal 5
NZ - Nuova Zelanda 5
AZ - Azerbaigian 4
HN - Honduras 4
HU - Ungheria 4
NO - Norvegia 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
BG - Bulgaria 3
CR - Costa Rica 3
IS - Islanda 3
JO - Giordania 3
KZ - Kazakistan 3
OM - Oman 3
BF - Burkina Faso 2
EE - Estonia 2
GT - Guatemala 2
JM - Giamaica 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
MC - Monaco 2
RS - Serbia 2
SN - Senegal 2
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
Totale 19.631
Città #
Milan 1.637
Ashburn 861
San Jose 861
Singapore 842
Fairfield 647
Chandler 559
Woodbridge 546
Hong Kong 462
Houston 431
Jacksonville 357
Dallas 333
Ann Arbor 315
Seattle 269
Beijing 262
Wilmington 235
Como 233
Council Bluffs 230
Cambridge 223
Dublin 215
Los Angeles 214
The Dalles 209
Boardman 181
Nyköping 179
Princeton 175
Chicago 161
New York 155
Rome 139
Dearborn 124
Lauterbourg 121
Izmir 110
Ho Chi Minh City 100
Dong Ket 91
Hanoi 85
Munich 85
London 82
Santa Clara 75
Helsinki 72
Varese 72
Buffalo 63
São Paulo 62
Tokyo 55
San Diego 53
Turku 45
Orem 44
Mexico City 42
Warsaw 41
Washington 40
Frankfurt am Main 39
Montreal 38
Salt Lake City 38
Denver 35
Des Moines 35
Stockholm 35
Brooklyn 31
Nuremberg 31
Guangzhou 29
Ogden 29
Manchester 28
Brussels 27
Johannesburg 27
Shanghai 27
Gallarate 26
Brno 25
Chennai 25
Elk Grove Village 25
Atlanta 24
Poplar 24
San Francisco 24
Amsterdam 23
Toronto 23
Phoenix 21
Vienna 20
Düsseldorf 19
Kocaeli 19
Boston 18
Magnago 16
Tampa 16
Hefei 14
Abuja 13
Cantù 13
Genoa 13
Verona 13
Da Nang 12
Kunming 12
Palermo 12
Tianjin 12
Basingstoke 11
Berlin 11
Cavaria con Premezzo 11
Jinan 11
Las Vegas 11
Monza 11
Moscow 11
Norwalk 11
Pittsburgh 11
Pune 11
San Mateo 11
Ankara 10
Barcelona 10
Chengdu 10
Totale 13.455
Nome #
Polarization of Tumor Infiltrating Leukocytes from Innate Immunity and their role in the Pro-angiogenic Phenotype in NSCLC 307
Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer 301
Natural killer cells from patients with malignant or inflammatory pleural effusions display decreased cytotoxicity and decidual NK-like phenotype 282
Myeloid derived suppressor cells interactions with natural killer cells and pro-angiogenic activities: roles in tumor progression 270
Environmental impact of multi-wall carbon nanotubes in a novel model of exposure: Systemic distribution, macrophage accumulation, and amyloid deposition 266
Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders? 254
Cancer stem cells and the tumor microenvironment: Interplay in tumor heterogeneity 251
A think tank of TINK/TANKs: Tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis 248
Proline Dehydrogenase affects lung cancer cell proliferation by inducing ROS and cellular senescence 246
Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies 240
Biomarkers of cancer angioprevention for clinical studies 238
Cardiovascular active peptides of marine origin with ACE inhibitory activities: Potential role as anti-hypertensive drugs and in prevention of SARSCoV-2 infection 235
Potential chemopreventive activities of a polyphenol rich purified extract from olive mill wastewater on colon cancer cells 233
Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization 232
Natural killer cells from patients with either malignant or inflammatory pleural effusions display decreased cytotoxic capacity and decidual-like phenotype 224
Natural killer cells as key players of tumor progression and angiogenesis: old and novel tools to divert their pro-tumor activities into potent anti-tumor effects 223
Effect of a Purified Extract of Olive Mill Waste Water on Endothelial Cell Proliferation, Apoptosis, Migration and Capillary-Like Structure in vitro and in vivo. 221
Acetyl-L-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways 217
Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues 216
Unravelling the role of proline dehydrogenase (PRODH) in lung adenocarcinoma: implications for cellular senescence and the tumor microenvironment 215
Systemic distribution of single-walled carbon nanotubes in a novel model: alteration of biochemical parameters, metabolic functions, liver accumulation, and inflammation in vivo 215
The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer 212
Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ros production in endothelial cells and cardiomyocytes 210
Proffered Paper: The pro-angiogenic phenotype of natural killer cells infiltrating squamous cell carcinoma lung cancer 208
SANIST: optimization of a technology for compound identification based on the European Union directive with applications in forensic, pharmaceutical and food analyses 208
Inflammatory angiogenesis and the tumor microenvironment as targets for cancer therapy and prevention 206
Orchestration of angiogenesis by immune cells 201
Fenretinide (4-HPR) targets caspase-9, ERK 1/2 and the Wnt3a/β-catenin pathway in medulloblastoma cells and medulloblastoma cell spheroids 194
Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors 194
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment 194
SANIST: A rapid mass spectrometric SACI/ESI data acquisition and elaboration platform for verifying potential candidate biomarkers 193
Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy 192
Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: Implications for immunotherapy 191
The pro-angiogenic phenotype and functions of colorectal cancer tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells 188
Paradoxic effects of metformin on endothelial cells and angiogenesis. 184
Tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells: a new paradigm in colorectal cancer angiogenesis 183
Proline Dehydrogenase as a player in acquired resistance to Tyrosine Kinase Inhibitors 175
The Angiogenic Switch: Role of Immune Cells 172
Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation 169
The ovarian cancer tumor immune microenvironment (TIME) as target for therapy: a focus on innate immunity cells as therapeutic effectors 169
Natural killer cells from pleural effusions are responsive to interleukin-2 but are endowed with a potent pro-angiogenic feature 168
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation 167
Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves' disease patients during methimazole treatment 165
A potential role of human RNASET2 overexpression in the pathogenesis of Graves’ disease 162
Mutant alleles in Aicardi-Goutieres syndrome patients produce a disfunctional RNASET2 protein associated with alterations in interferon signalling. 161
Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis 161
MiR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2 160
Prostate cancer peripheral blood NK cells show enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 production, and secrete monocyte-recruiting and polarizing factors. 160
Natural killer cells from malignant pleural effusion show a decidual-like phenotype and an alternative activatory state. 159
Natural killer cells infiltrating colo-rectal cancer are switched towards the decidual-like pro-angiogenic CD56brightCD16- NK cell subset 157
Downregulation of pro-inflammatory and pro-angiogenic pathways in prostate cancer cells by a polyphenol-rich extract from olive mill wastewater 152
STAT3 and STAT5 drive the pro-angiogenic NK cell polarization in colorectal cancer patients 150
Tumor infiltrating (TINKs) and tumor associated (TANKs) from colorectal cancer patients are proangiogenic and express angiogenin and the MMP9-TIMP2, similar to decidual NK cells 150
Pleural effusion NK cells from metastatic tumors display pro-angiogenic features and pleural effusion fluids block their response to IL-2 treatment 149
Innate immunity driving tumor angiogenesis: the role of natural killer cells in non-small cell lung cancer (NSCLC) 148
The human RNASET2 alarmin-like molecule differentially affects prostate cancer cells behavior in both cell autonomous and non-cell autonomous manners 146
Phenotypic and functional characterization of tumor infiltrating natural killer cells: role in tumor angiogenesis 144
Microalgal derivatives as potential nutraceutical and food supplements for human health: A focus on cancer prevention and interception 143
Nutraceuticals and “repurposed” drugs of phytochemical origin in prevention and interception of chronic degenerative diseases and cancer 143
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: results of a prospective cohort study of 365 patients 141
Subcapsular sinus macrophages promote melanoma metastasis to the sentinel lymph nodes via an IL-1α-STAT3 axis 140
Functional and phenotypic characterization of tumor infiltrating NK cells. 140
When a Friend Becomes Your Enemy: Natural Killer Cells in Atherosclerosis and Atherosclerosis-Associated Risk Factors 139
The Pharmacologist’s Point of View: Mechanisms of Cardiotoxicity 136
The NK cells phenotype and function in resected non small cell lung cancer: differences between squamous and adenocarcinoma. 136
Adipose mesenchymal stem cell-derived soluble factors, produced under hypoxic condition, efficiently support in vivo angiogenesis 134
Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher 134
Neutrophil and Natural Killer Cell Interactions in Cancers: Dangerous Liaisons Instructing Immunosuppression and Angiogenesis 134
The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectors 133
Phenotypic and functional characterization of tumor infiltrating natural killer cells: role in tumor angiogenesis 133
VEGFR2 and CXCR4 pathways are modulated by acetyl-l-Carnitine that acts as an anti-angiogenic agent 133
Circulating and tumor infiltrating natural killer cells in renal cancer patients express the CD9 and CD49a decidual markers and have increased activation of STAT3 132
Tumor-infiltrating (TINKs) and tumor-associated (TANKs) natural killer cells: a new player in the inflammatory orchestration of tumor angiogenesis in colon cancer 132
Human RNASET2: A Highly Pleiotropic and Evolutionary Conserved Tumor Suppressor Gene Involved in the Control of Ovarian Cancer Pathogenesis 131
Innate immunity driving tumor angiogenesis: the role of natural killer cells in non small cell lung cancer (NSCLC) 131
The role of tumor infiltrating and tumor associated natural killer cells in promotion of angiogenesis in colorectal cancer patients 130
Functional and phenotypic characterization of tumor infiltrating NK cells to identify novel targets for anticancer therapy. 130
Human Dental Pulp Mesenchymal Stem Cell-Derived Soluble Factors Combined with a Nanostructured Scaffold Support theGeneratio of a Vascular Network In Vivo 129
Prostate cancer associated natural killer cells show a pro-angiogenic and pro-inflammatory phenotype. 129
Natural killer cells from malignant pleural effusion are switched toward an NK proangiogenic polarization 128
A Polyphenol-Rich Extract of Olive Mill Wastewater Enhances Cancer Chemotherapy Effects, While Mitigating Cardiac Toxicity 128
NK cells-modulation of tumor angiogenesis. 127
The role of natural killer cells in lung cancer angiogenesis 126
Natural compounds of marine origin as inducers of immunogenic cell death (ICD): potential role for cancer interception and therapy 126
Metabolic Rewiring in the Tumor Microenvironment to Support Immunotherapy: A Focus on Neutrophils, Polymorphonuclear Myeloid-Derived Suppressor Cells and Natural Killer Cells 126
Proline Dehydrogenase (PRODH) Is Expressed in Lung Adenocarcinoma and Modulates Cell Survival and 3D Growth by Inducing Cellular Senescence 125
NK cells as modulators of tumor angiogenesis 125
Serum steroid ratio profiles in prostate cancer: A new diagnostic tool toward a personalized medicine approach 125
An Olive Oil Mill Wastewater Extract Improves Chemotherapeutic Activity Against Breast Cancer Cells While Protecting From Cardiotoxicity 124
The cell-autonomous and non-cell autonomous activities of the alarmin-like RNASET2 protein in prostate cancer models 121
N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity 121
A PSA-guided approach for a better diagnosis of prostatic adenocarcinoma based on MALDI profiling and peptide identification 119
Use of extract of vegetation waters in the regeneration of epithelial tissue 113
TIMP1 and TIMP2 downregulate TGFβ induced decidual-like phenotype in natural killer cells 111
Dental pulp mesenchymal stem cell (DPSCs)-derived soluble factors, produced under hypoxic conditions, support angiogenesis via endothelial cell activation and generation of M2-like macrophages 110
The Dual Role of Natural Killer Cells During Tumor Progression and Angiogenesis: Implications for Tumor Microenvironment-targeted Immunotherapies. 107
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation 102
Microbiota-Derived Natural Products Targeting Cancer Stem Cells: Inside the Gut Pharma Factory 101
Proline Dehydrogenase as new marker and target in EGFR mutant Non-Small Cell Lung carcinoma 101
Effects of Amorphous Calcium Phosphate Administration on Dental Sensitivity during In-Office and At-Home Interventions 101
Totale 16.866
Categoria #
all - tutte 81.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.183


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.015 148 50 21 27 56 51 60 61 174 173 63 131
2022/20231.624 143 105 114 208 116 324 7 204 189 75 76 63
2023/20242.837 382 390 379 511 580 198 23 60 55 115 14 130
2024/20252.832 47 32 345 146 216 146 135 147 315 412 314 577
2025/20266.890 466 385 427 951 777 332 1.224 453 639 529 389 318
2026/2027148 148 0 0 0 0 0 0 0 0 0 0 0
Totale 19.985